Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Return on Invested Capital (2021 - 2024)

Historic Return on Invested Capital for Trinity Biotech (TRIB) over the last 5 years, with Q4 2024 value amounting to 0.72%.

  • Trinity Biotech's Return on Invested Capital fell 6300.0% to 0.72% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.72%, marking a year-over-year decrease of 6300.0%. This contributed to the annual value of 0.76% for FY2024, which is 13600.0% down from last year.
  • Trinity Biotech's Return on Invested Capital amounted to 0.72% in Q4 2024, which was down 6300.0% from 0.5% recorded in Q3 2024.
  • Trinity Biotech's 5-year Return on Invested Capital high stood at 98.06% for Q3 2021, and its period low was 70.01% during Q2 2021.
  • Over the past 4 years, Trinity Biotech's median Return on Invested Capital value was 0.61% (recorded in 2024), while the average stood at 1.57%.
  • Within the past 5 years, the most significant YoY rise in Trinity Biotech's Return on Invested Capital was 700600bps (2022), while the steepest drop was -989600bps (2022).
  • Quarter analysis of 4 years shows Trinity Biotech's Return on Invested Capital stood at 26.39% in 2021, then tumbled by -133bps to 8.79% in 2022, then soared by 115bps to 1.34% in 2023, then tumbled by -47bps to 0.72% in 2024.
  • Its Return on Invested Capital was 0.72% in Q4 2024, compared to 0.5% in Q3 2024 and 1.14% in Q1 2024.